Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

N-3 Fatty Acid EPA Supplementation in Cancer Patients Receiving Abdominal Radiotherapy - A Randomised Controlled Trial.

NCT04687124 is registered in ClinicalTrials.gov with Jens Rikardt Andersen as lead sponsor.

NCT NCT04687124
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04687124 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
N-3 Fatty Acid EPA Supplementation in Cancer Patients Receiving Abdominal Radiotherapy - A Randomised Controlled Trial.
Lead sponsor
Jens Rikardt Andersen
Phase
Phase 4
Overall status
Unknown status
Start date
February 15, 2018
Completion date
February 28, 2021
Enrollment
26 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal cancer, energy supply, protein deficiency, radiotherapy; complications, weight loss